Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180717040509N3Phase 3Completed
Phase 3, randomised, double-blind trial comparing Ondansetron, Metoclopramide and Placebo (3 arms). Primary endpoints: Discomfort, Severity of pain and 1 more. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180717040509N3.